CHS828 : Photolabile ruthenium complexes to cage and release a highly cytotoxic anticancer agent
ASN007 : ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors
PI-103 : PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML
Fedratinib : Pharmacokinetics and tolerability of fedratinib, an oral, selective Janus kinase 2 inhibitor, in subjects with renal or hepatic impairment